Joseph Decker, MD
Ophthalmology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 25
- 5 carriers
- Office
- 1
Offices
1 location · San Jose Eye Institute Medical Corporation · 2 clinicians in this group
Looking this up.
Plans that list them
25 plans · 5 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Decker’s office at (408) 279-4664 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
25 of 25 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence G11266 · Current
Licensed to practise in California · since 1965 · expires 2028-02-29 · University of Illinois College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$81,649
Medicare paid this office $81,649 for 317 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Established patient complete exam of visual system | 243 | $36,403 | $104 |
| Return visit (30+ min) | 106 | $15,848 | $100 |
| Imaging of retina | 192 | $8,687 | $35 |
| New patient complete exam of visual system | 43 | $5,046 | $117 |
| Exam of visual field with extended testing | 78 | $4,666 | $53 |
See all 9 services
| Established patient complete exam of visual system | 243 | $36,403 | $104 |
| Return visit (30+ min) | 106 | $15,848 | $100 |
| Imaging of retina | 192 | $8,687 | $35 |
| New patient complete exam of visual system | 43 | $5,046 | $117 |
| Exam of visual field with extended testing | 78 | $4,666 | $53 |
| Imaging of optic nerve | 104 | $3,605 | $31 |
| Exam of the internal drainage system of eye | 97 | $2,616 | $24 |
| Established patient problem focused exam of visual system | 17 | $1,454 | $73 |
| Photography of the retina | 41 | $1,323 | $31 |
Who their Medicare patients are
317 Original Medicare patients in 2024. Average age 78 · Women 61% · Also on Medicaid 9% · Health risk score 1.07. At or below the middle of the specialty; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 73% · Diabetes 34% · Coronary heart disease 22% · Atrial fibrillation 19% · Chronic kidney disease 17% · Cancer 17% · Heart failure 13% · COPD 10% · Depression 8% · Dementia 7% · Stroke 3%.
The office billed $252,955, Medicare allowed $124,017 and paid $81,649; for 1,209 services of 18 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 317 | 1,209 | 78 | 1.07 | $252,955 | $81,649 |
| 2023 | 335 | 1,440 | 78 | 1.07 | $287,103 | $96,059 |
| 2022 | 378 | 1,707 | 78 | 1.04 | $337,807 | $112,451 |
| 2021 | 366 | 1,415 | 78 | 0.97 | $286,595 | $106,863 |
| 2020 | 241 | 668 | 80 | 1.09 | $66,674 | $34,474 |
| 2019 | 537 | 2,331 | 79 | 1.19 | $237,762 | $161,394 |
| 2018 | 584 | 2,340 | 79 | 1.17 | $233,967 | $158,220 |
| 2017 | 593 | 2,446 | 79 | 1.17 | $248,983 | $162,916 |
| 2016 | 604 | 2,451 | 79 | 1.31 | $249,920 | $162,520 |
| 2015 | 596 | 2,773 | 79 | 1.22 | $275,591 | $188,912 |
| 2014 | 608 | 2,323 | 79 | 1.11 | $229,368 | $153,315 |
| 2013 | 652 | 2,019 | 79 | 1.15 | $248,110 | $159,530 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Established patient complete exam of visual system | 224 | $32,070 | $108 |
| Return visit (30+ min) | 142 | $27,602 | $105 |
| Imaging of retina | 209 | $9,169 | $35 |
| New patient complete exam of visual system | 50 | $5,708 | $114 |
| Exam of visual field with extended testing | 80 | $4,794 | $56 |
| Imaging of optic nerve | 101 | $3,506 | $31 |
| Exam of the internal drainage system of eye | 101 | $2,958 | $25 |
| Established patient problem focused exam of visual system | 37 | $2,640 | $68 |
| Microfluid analysis of tears | 47 | $2,335 | $22 |
| Photography of the retina | 44 | $1,547 | $33 |
| Short return visit (20+ min) | 11 | $1,005 | $67 |
| Ultrasound scan of cornea to determine thickness | 14 | $135 | $9 |
2022: 13 services
| Established patient complete exam of visual system | 257 | $36,774 | $105 |
| Return visit (30+ min) | 148 | $25,135 | $102 |
| Imaging of retina | 202 | $8,945 | $36 |
| New patient complete exam of visual system | 58 | $6,767 | $117 |
| Established patient problem focused exam of visual system | 77 | $6,710 | $81 |
| Exam of visual field with extended testing | 104 | $6,339 | $57 |
| Microfluid analysis of tears | 77 | $4,809 | $22 |
| Imaging of optic nerve | 117 | $4,421 | $32 |
| Closure of tear duct opening using plug | 12 | $3,056 | $113 |
| Exam of the internal drainage system of eye | 95 | $2,779 | $24 |
| Photography of the retina | 47 | $1,389 | $29 |
| Short return visit (20+ min) | 12 | $724 | $60 |
| Ultrasound scan of cornea to determine thickness | 13 | $171 | $11 |
2021: 14 services
| Established patient complete exam of visual system | 232 | $34,686 | $120 |
| Return visit (30+ min) | 124 | $22,581 | $116 |
| Established patient problem focused exam of visual system | 97 | $9,831 | $84 |
| Imaging of retina | 169 | $7,721 | $40 |
| Exam of visual field with extended testing | 86 | $5,948 | $65 |
| New patient complete exam of visual system | 43 | $5,705 | $133 |
| Imaging of optic nerve | 116 | $4,472 | $36 |
| Exam of the internal drainage system of eye | 93 | $2,999 | $27 |
| Laser repair to improve eye fluid flow | 12 | $2,966 | $247 |
| Microfluid analysis of tears | 41 | $2,248 | $22 |
| Short return visit (20+ min) | 29 | $2,143 | $67 |
| Photography of the retina | 53 | $1,955 | $37 |
| Imaging of front third of eye | 11 | $244 | $22 |
| Ultrasound scan of cornea to determine thickness | 12 | $130 | $11 |
2020: 11 services
| Established patient problem focused exam of visual system | 119 | $12,907 | $75 |
| Established patient complete exam of visual system | 89 | $5,735 | $64 |
| Short return visit (20+ min) | 61 | $2,632 | $42 |
| Exam of visual field with extended testing | 48 | $2,504 | $49 |
| Imaging of optic nerve | 64 | $2,027 | $30 |
| Imaging of retina | 63 | $1,885 | $29 |
| Microfluid analysis of tears | 23 | $1,246 | $22 |
| Photography of the retina | 27 | $1,178 | $44 |
| Return visit (30+ min) | 12 | $736 | $61 |
| Imaging of front third of eye | 15 | $421 | $25 |
| Exam of the internal drainage system of eye | 19 | $352 | $19 |
2019: 15 services
| Established patient complete exam of visual system | 371 | $51,828 | $109 |
| Short return visit (20+ min) | 272 | $30,752 | $61 |
| Established patient problem focused exam of visual system | 155 | $16,756 | $78 |
| Imaging of retina | 198 | $10,520 | $39 |
| Laser repair to improve eye fluid flow | 37 | $8,853 | $233 |
| Exam of visual field with extended testing | 135 | $8,173 | $58 |
| Closure of tear duct opening using plug | 18 | $5,412 | $108 |
| New patient complete exam of visual system | 49 | $5,374 | $110 |
| Imaging of optic nerve | 137 | $5,197 | $34 |
| Photography of the retina | 86 | $4,263 | $50 |
| Removal of recurring cataract in lens capsule using a laser | 11 | $3,988 | $307 |
| Exam of the internal drainage system of eye | 110 | $3,331 | $24 |
| Microfluid analysis of tears | 57 | $3,018 | $22 |
| Imaging of front third of eye | 15 | $470 | $31 |
| Ultrasound scan of cornea to determine thickness | 25 | $332 | $11 |
2018: 14 services
| Established patient complete exam of visual system | 390 | $50,145 | $106 |
| Short return visit (20+ min) | 297 | $34,117 | $60 |
| Established patient problem focused exam of visual system | 143 | $13,596 | $75 |
| Imaging of retina | 181 | $9,515 | $38 |
| Exam of visual field with extended testing | 140 | $7,810 | $53 |
| New patient complete exam of visual system | 60 | $7,363 | $123 |
| Laser repair to improve eye fluid flow | 29 | $6,942 | $231 |
| Removal of recurring cataract in lens capsule using a laser | 16 | $5,046 | $297 |
| Imaging of optic nerve | 142 | $4,993 | $34 |
| Closure of tear duct opening using plug | 17 | $4,287 | $107 |
| Photography of the retina | 70 | $3,741 | $53 |
| Microfluid analysis of tears | 63 | $3,701 | $22 |
| Exam of the internal drainage system of eye | 109 | $3,279 | $24 |
| Ultrasound scan of cornea to determine thickness | 21 | $330 | $14 |
2017: 15 services
| Established patient complete exam of visual system | 350 | $40,535 | $100 |
| Short return visit (20+ min) | 312 | $38,093 | $60 |
| Established patient problem focused exam of visual system | 227 | $19,829 | $69 |
| Laser repair to improve eye fluid flow | 47 | $11,963 | $218 |
| Imaging of retina | 175 | $8,688 | $36 |
| Exam of visual field with extended testing | 136 | $7,944 | $54 |
| New patient complete exam of visual system | 69 | $7,810 | $113 |
| Imaging of optic nerve | 149 | $5,192 | $33 |
| Removal of recurring cataract in lens capsule using a laser | 16 | $5,093 | $283 |
| Photography of the retina | 73 | $4,467 | $61 |
| Closure of tear duct opening using plug | 14 | $3,440 | $107 |
| Exam of the internal drainage system of eye | 109 | $2,931 | $22 |
| Microfluid analysis of tears | 51 | $2,576 | $22 |
| Ultrasound scan of cornea to determine thickness | 29 | $428 | $12 |
| Examination of eye by ophthalmoscope with retinal drawing | 13 | $322 | $25 |
2016: 14 services
| Short return visit (20+ min) | 342 | $39,948 | $58 |
| Established patient complete exam of visual system | 295 | $31,382 | $101 |
| Established patient problem focused exam of visual system | 256 | $23,327 | $69 |
| Laser repair to improve eye fluid flow | 43 | $11,564 | $251 |
| Exam of visual field with extended testing | 142 | $8,007 | $54 |
| New patient complete exam of visual system | 64 | $7,645 | $119 |
| Imaging of retina | 132 | $7,413 | $40 |
| Imaging of optic nerve | 152 | $6,132 | $38 |
| Closure of tear duct opening using plug | 26 | $6,002 | $105 |
| Removal of recurring cataract in lens capsule using a laser | 18 | $5,795 | $290 |
| Photography of the retina | 72 | $5,284 | $72 |
| Microfluid analysis of tears | 67 | $3,484 | $22 |
| Exam of the internal drainage system of eye | 124 | $3,322 | $22 |
| Ultrasound scan of cornea to determine thickness | 30 | $407 | $12 |
2015: 14 services
| Short return visit (20+ min) | 355 | $44,667 | $61 |
| Established patient complete exam of visual system | 362 | $38,528 | $97 |
| Established patient problem focused exam of visual system | 254 | $24,427 | $75 |
| Laser repair to improve eye fluid flow | 42 | $16,695 | $321 |
| Exam of visual field with extended testing | 155 | $9,912 | $60 |
| Closure of tear duct opening using plug | 35 | $9,318 | $107 |
| Imaging of retina | 138 | $8,156 | $43 |
| New patient complete exam of visual system | 62 | $7,709 | $124 |
| Photography of the retina | 87 | $6,993 | $79 |
| Imaging of optic nerve | 157 | $6,532 | $39 |
| Microfluid analysis of tears | 109 | $6,477 | $22 |
| Removal of recurring cataract in lens capsule using a laser | 11 | $3,579 | $298 |
| Exam of the internal drainage system of eye | 107 | $3,097 | $23 |
| Ultrasound scan of cornea to determine thickness | 43 | $566 | $13 |
2014: 13 services
| Short return visit (20+ min) | 337 | $37,836 | $58 |
| Established patient problem focused exam of visual system | 278 | $24,078 | $70 |
| Established patient complete exam of visual system | 242 | $23,257 | $94 |
| Laser repair to improve eye fluid flow | 42 | $15,059 | $327 |
| Exam of visual field with extended testing | 150 | $9,183 | $57 |
| Closure of tear duct opening using plug | 36 | $8,542 | $110 |
| Imaging of retina | 132 | $6,812 | $42 |
| Photography of the retina | 71 | $5,817 | $79 |
| Microfluid analysis of tears | 91 | $5,622 | $22 |
| Imaging of optic nerve | 114 | $4,438 | $38 |
| New patient complete exam of visual system | 33 | $3,830 | $116 |
| Exam of the internal drainage system of eye | 73 | $1,921 | $23 |
| Ultrasound scan of cornea to determine thickness | 34 | $477 | $14 |
2013: 14 services
| Established patient problem focused exam of visual system | 329 | $28,837 | $69 |
| Short return visit (20+ min) | 326 | $28,723 | $56 |
| Established patient complete exam of visual system | 221 | $21,628 | $97 |
| Removal of cataract with insertion of prosthetic lens | 28 | $20,962 | $599 |
| Laser repair to improve eye fluid flow | 33 | $11,608 | $322 |
| Exam of visual field with extended testing | 149 | $8,499 | $56 |
| Closure of tear duct opening using plug | 32 | $8,246 | $113 |
| Photography of the retina | 95 | $6,647 | $70 |
| Imaging of retina | 112 | $5,450 | $40 |
| New patient complete exam of visual system | 45 | $4,874 | $108 |
| Imaging of optic nerve | 121 | $4,678 | $38 |
| Measurement of corneal curvature and depth of eye | 29 | $2,032 | $58 |
| Exam of the internal drainage system of eye | 56 | $1,288 | $21 |
| Ultrasound scan of cornea to determine thickness | 22 | $268 | $12 |
Drugs they prescribed that Part D paid
$262,645
Pharmacies billed $262,645 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 748) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.
212 generic and 536 brand-name prescriptions · $262,645 in drug cost · 11 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Restasis | 67 | $58,875 | $879 |
| Cequa | 40 | $35,284 | $882 |
| Tyrvaya | 43 | $32,497 | $756 |
| Vyzulta | 49 | $26,366 | $538 |
| Xiidra | 17 | $24,249 | $1,426 |
See all 15 drugs
| Restasis | 67 | $58,875 | $879 |
| Cequa | 40 | $35,284 | $882 |
| Tyrvaya | 43 | $32,497 | $756 |
| Vyzulta | 49 | $26,366 | $538 |
| Xiidra | 17 | $24,249 | $1,426 |
| Cyclosporine | 50 | $21,830 | $437 |
| Miebo | 22 | $16,436 | $747 |
| Rocklatan | 25 | $12,493 | $500 |
| Simbrinza | 12 | $4,239 | $353 |
| Latanoprost | 236 | $2,755 | $12 |
| Travoprost | 15 | $2,425 | $162 |
| Brimonidine | 42 | $2,374 | $57 |
| Timolol Maleate | 12 | $664 | $55 |
| Moxifloxacin | 17 | $308 | $18 |
| Erythromycin | 22 | $213 | $10 |
Year by year
| 2024 | 748 | 182 | 0% (0) | 72% | $262,645 |
| 2023 | 769 | 175 | 0% (0) | 72% | $277,757 |
| 2022 | 804 | 185 | None | 75% | $267,330 |
| 2021 | 758 | 171 | 0% (0) | 79% | $237,058 |
| 2020 | 888 | 172 | 0% (0) | 68% | $231,322 |
| 2019 | 1,090 | 243 | 0% (0) | 69% | $269,521 |
| 2018 | 1,207 | 248 | 0% (0) | 69% | $259,102 |
| 2017 | 1,370 | 251 | 0% (0) | 64% | $233,831 |
| 2016 | 1,255 | 255 | 0% (0) | 66% | $201,369 |
| 2015 | 1,296 | 249 | 0% (0) | 64% | $162,075 |
| 2014 | 1,273 | 217 | 0% (0) | 63% | $142,052 |
| 2013 | 1,384 | 232 | 0% (0) | 65% | $147,118 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 12 drugs
| Restasis | 114 | $99,783 | $875 |
| Cequa | 52 | $44,176 | $850 |
| Xiidra | 41 | $40,064 | $977 |
| Vyzulta | 36 | $21,276 | $591 |
| Cyclosporine | 32 | $14,239 | $445 |
| Simbrinza | 43 | $9,228 | $215 |
| Rocklatan | 18 | $7,121 | $396 |
| Travoprost | 29 | $5,227 | $180 |
| Latanoprost | 209 | $4,847 | $23 |
| Alphagan P | 16 | $4,752 | $297 |
| Brimonidine | 13 | $2,192 | $169 |
| Erythromycin | 75 | $841 | $11 |
2022: 13 drugs
| Restasis | 98 | $78,524 | $801 |
| Xiidra | 82 | $70,517 | $860 |
| Cequa | 40 | $29,486 | $737 |
| Vyzulta | 50 | $25,504 | $510 |
| Rocklatan | 42 | $14,439 | $344 |
| Simbrinza | 33 | $8,283 | $251 |
| Alphagan P | 31 | $7,971 | $257 |
| Latanoprost | 236 | $5,390 | $23 |
| Travoprost | 31 | $4,440 | $143 |
| Combigan | 12 | $2,977 | $248 |
| Brimonidine | 21 | $1,877 | $89 |
| Dorzolamide-Timolol | 18 | $875 | $49 |
| Erythromycin | 32 | $368 | $11 |
2021: 13 drugs
| Xiidra | 103 | $78,624 | $763 |
| Restasis | 88 | $63,926 | $726 |
| Cequa | 29 | $19,500 | $672 |
| Rocklatan | 34 | $11,935 | $351 |
| Vyzulta | 27 | $11,087 | $411 |
| Travoprost | 33 | $6,725 | $204 |
| Latanoprost | 239 | $6,360 | $27 |
| Simbrinza | 26 | $4,919 | $189 |
| Alphagan P | 25 | $4,602 | $184 |
| Brimonidine | 14 | $1,666 | $119 |
| Dorzolamide-Timolol | 17 | $737 | $43 |
| Moxifloxacin | 13 | $399 | $31 |
| Erythromycin | 24 | $237 | $10 |
2020: 16 drugs
| Xiidra | 77 | $56,553 | $734 |
| Restasis | 53 | $44,486 | $839 |
| Travatan Z | 83 | $24,878 | $300 |
| Rocklatan | 45 | $15,801 | $351 |
| Cequa | 27 | $15,097 | $559 |
| Vyzulta | 35 | $14,072 | $402 |
| Lumigan | 20 | $8,357 | $418 |
| Latanoprost | 306 | $8,179 | $27 |
| Travoprost | 47 | $7,998 | $170 |
| Azopt | 16 | $7,772 | $486 |
| Simbrinza | 22 | $6,864 | $312 |
| Alphagan P | 25 | $5,294 | $212 |
| Dorzolamide-Timolol | 19 | $1,116 | $59 |
| Brimonidine | 18 | $1,063 | $59 |
| Dorzolamide | 16 | $525 | $33 |
| Erythromycin | 11 | $150 | $14 |
2019: 18 drugs
| Restasis | 78 | $66,209 | $849 |
| Travatan Z | 176 | $47,348 | $269 |
| Xiidra | 62 | $43,566 | $703 |
| Rhopressa | 66 | $21,545 | $326 |
| Lumigan | 63 | $16,756 | $266 |
| Vyzulta | 41 | $13,514 | $330 |
| Azopt | 26 | $10,186 | $392 |
| Latanoprost | 334 | $8,297 | $25 |
| Lotemax | 18 | $6,160 | $342 |
| Simbrinza | 27 | $5,413 | $200 |
| Rocklatan | 11 | $4,684 | $426 |
| Alphagan P | 13 | $3,490 | $268 |
| Acetazolamide | 12 | $1,179 | $98 |
| Brimonidine | 12 | $1,068 | $89 |
| Prednisolone Acetate | 20 | $1,064 | $53 |
| Dorzolamide | 19 | $663 | $35 |
| Ketorolac Tromethamine | 13 | $588 | $45 |
| Erythromycin | 22 | $213 | $10 |
2018: 19 drugs
| Restasis | 94 | $65,844 | $700 |
| Travatan Z | 180 | $51,735 | $287 |
| Xiidra | 70 | $47,604 | $680 |
| Lumigan | 60 | $13,248 | $221 |
| Rhopressa | 39 | $10,648 | $273 |
| Simbrinza | 52 | $10,118 | $195 |
| Latanoprost | 414 | $9,014 | $22 |
| Azopt | 27 | $8,918 | $330 |
| Lotemax | 24 | $6,445 | $269 |
| Vyzulta | 11 | $3,624 | $329 |
| Zioptan | 13 | $2,459 | $189 |
| Alphagan P | 11 | $2,305 | $210 |
| Brimonidine | 13 | $2,241 | $172 |
| Durezol | 11 | $1,912 | $174 |
| Prednisolone Acetate | 19 | $1,342 | $71 |
| Ketorolac Tromethamine | 19 | $825 | $43 |
| Dorzolamide-Timolol | 22 | $747 | $34 |
| Moxifloxacin | 14 | $533 | $38 |
| Erythromycin | 15 | $141 | $9 |
2017: 20 drugs
| Restasis | 100 | $56,690 | $567 |
| Travatan Z | 220 | $55,546 | $252 |
| Xiidra | 62 | $30,325 | $489 |
| Lumigan | 74 | $15,829 | $214 |
| Simbrinza | 78 | $13,877 | $178 |
| Azopt | 27 | $9,097 | $337 |
| Latanoprost | 457 | $8,359 | $18 |
| Lotemax | 26 | $6,819 | $262 |
| Combigan | 23 | $5,063 | $220 |
| Zioptan | 24 | $4,287 | $179 |
| Alphagan P | 14 | $2,498 | $178 |
| Brimonidine | 13 | $2,124 | $163 |
| Vigamox | 12 | $1,873 | $156 |
| Olopatadine | 23 | $1,528 | $66 |
| Prednisolone Acetate | 24 | $1,472 | $61 |
| Moxifloxacin | 15 | $1,381 | $92 |
| Dorzolamide-Timolol | 28 | $1,066 | $38 |
| Ketorolac Tromethamine | 16 | $668 | $42 |
| Cephalexin | 11 | $144 | $13 |
| Timolol Maleate | 13 | $80 | $6 |
2016: 14 drugs
| Restasis | 108 | $60,441 | $560 |
| Travatan Z | 195 | $49,870 | $256 |
| Lumigan | 93 | $21,282 | $229 |
| Simbrinza | 101 | $17,177 | $170 |
| Lotemax | 35 | $9,311 | $266 |
| Latanoprost | 439 | $6,883 | $16 |
| Zioptan | 37 | $6,434 | $174 |
| Azopt | 16 | $6,127 | $383 |
| Brimonidine | 19 | $2,775 | $146 |
| Pazeo | 12 | $1,811 | $151 |
| Xalatan | 11 | $1,693 | $154 |
| Timolol Maleate | 17 | $1,464 | $86 |
| Dorzolamide-Timolol | 31 | $955 | $31 |
| Ketorolac Tromethamine | 17 | $669 | $39 |
2015: 16 drugs
| Restasis | 97 | $40,323 | $416 |
| Travatan Z | 202 | $40,303 | $200 |
| Lumigan | 106 | $21,813 | $206 |
| Simbrinza | 74 | $10,884 | $147 |
| Latanoprost | 504 | $6,872 | $14 |
| Brimonidine | 27 | $5,661 | $210 |
| Azopt | 15 | $5,213 | $348 |
| Vigamox | 26 | $3,593 | $138 |
| Lotemax | 16 | $3,590 | $224 |
| Timolol Maleate | 29 | $3,011 | $104 |
| Durezol | 18 | $2,699 | $150 |
| Zioptan | 11 | $1,648 | $150 |
| Dorzolamide-Timolol | 45 | $1,081 | $24 |
| Prednisolone Acetate | 12 | $864 | $72 |
| Dorzolamide | 11 | $229 | $21 |
| Erythromycin | 15 | $170 | $11 |
2014: 16 drugs
| Restasis | 82 | $33,372 | $407 |
| Travatan Z | 189 | $33,007 | $175 |
| Lumigan | 132 | $24,358 | $185 |
| Latanoprost | 526 | $8,852 | $17 |
| Alphagan P | 21 | $4,284 | $204 |
| Azopt | 16 | $4,121 | $258 |
| Brimonidine | 25 | $3,907 | $156 |
| Patanol | 16 | $3,428 | $214 |
| Vigamox | 30 | $3,377 | $113 |
| Simbrinza | 26 | $3,239 | $125 |
| Alrex | 16 | $3,027 | $189 |
| Pataday | 14 | $2,982 | $213 |
| Timolol Maleate | 21 | $2,186 | $104 |
| Dorzolamide-Timolol | 57 | $1,611 | $28 |
| Prednisolone Acetate | 12 | $790 | $66 |
| Dorzolamide | 15 | $349 | $23 |
2013: 22 drugs
| Restasis | 90 | $31,897 | $354 |
| Travatan Z | 183 | $27,611 | $151 |
| Lumigan | 133 | $22,689 | $171 |
| Latanoprost | 466 | $9,304 | $20 |
| Alphagan P | 47 | $8,026 | $171 |
| Brimonidine | 40 | $5,526 | $138 |
| Azopt | 24 | $4,972 | $207 |
| Bromday | 23 | $4,722 | $205 |
| Vigamox | 43 | $4,569 | $106 |
| Combigan | 14 | $2,593 | $185 |
| Dorzolamide-Timolol | 73 | $2,511 | $34 |
| Durezol | 22 | $2,422 | $110 |
| Alrex | 11 | $2,365 | $215 |
| Nevanac | 15 | $2,235 | $149 |
| Doxycycline Hyclate | 43 | $2,199 | $51 |
| Patanol | 11 | $1,483 | $135 |
| Tobramycin-Dexamethasone | 14 | $1,391 | $99 |
| Pataday | 11 | $1,386 | $126 |
| Timolol Maleate | 13 | $772 | $59 |
| Pilocarpine | 12 | $613 | $51 |
| Dorzolamide | 11 | $429 | $39 |
| Prednisolone Acetate | 14 | $364 | $26 |
Money from drug and device companies
$556 in 2025
| 2025 | 5 | 21 | None | $556 |
| 2024 | 6 | 14 | None | $411 |
| 2023 | 5 | 15 | None | $420 |
| 2022 | 4 | 10 | None | $204 |
| 2021 | 4 | 8 | None | $167 |
| 2020 | 1 | 1 | None | $24 |
| 2019 | 5 | 11 | None | $536 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Alcon Vision | Tryptyr | $238 | 7 payments
|
| Abbvie | Lumigan | $157 | 6 payments
|
| Bausch & Lomb Americas | Vyzulta | $75 | 4 payments
|
| Oyster Point Pharma | Tyrvaya | $44 | 2 payments
|
| Thea Pharma | Iyuzeh | $42 | 2 payments
|
See all 21 published payments
| Abbvie | Meals · 2025-12-20 | Lumigan | $32 |
| Abbvie | Meals · 2025-12-13 | Lumigan | $23 |
| Alcon Vision | Meals · 2025-12-09 | Tryptyr | $12 |
| Abbvie | Meals · 2025-11-21 | Lumigan | $28 |
| Alcon Vision | Meals · 2025-11-14 | Tryptyr | $12 |
| Alcon Vision | Meals · 2025-11-04 | Tryptyr | $122 |
| Thea Pharma | Meals · 2025-10-29 | Iyuzeh | $20 |
| Bausch & Lomb Americas | Meals · 2025-10-24 | Vyzulta | $15 |
| Bausch & Lomb Americas | Meals · 2025-10-08 | Vyzulta | $25 |
| Abbvie | Meals · 2025-09-20 | Lumigan | $33 |
| Thea Pharma | Meals · 2025-09-03 | Iyuzeh | $22 |
| Alcon Vision | Meals · 2025-08-16 | Tryptyr | $20 |
| Abbvie | Meals · 2025-08-15 | Lumigan | $12 |
| Abbvie | Meals · 2025-06-28 | Lumigan | $30 |
| Bausch & Lomb Americas | Meals · 2025-06-10 | Vyzulta | $20 |
| Alcon Vision | Meals · 2025-06-03 | Eysuvis | $22 |
| Alcon Vision | Meals · 2025-05-07 | Eysuvis | $20 |
| Alcon Vision | Meals · 2025-03-26 | Rocklatan | $30 |
| Oyster Point Pharma | Meals · 2025-02-07 | Tyrvaya | $30 |
| Bausch & Lomb Americas | Meals · 2025-02-03 | Vyzulta | $15 |
| Oyster Point Pharma | Meals · 2025-01-28 | Tyrvaya | $14 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $411
| Oyster Point Pharma | Tyrvaya | $221 | 5 payments
|
| Bausch & Lomb Americas | Vyzulta | $108 | 5 payments
|
| Abbvie | Lumigan | $29 | 1 payment
|
| RxSight | Rxsight Contact Lens | $25 | 1 payment
|
| Thea Pharma | Iyuzeh | $16 | 1 payment
|
| Tarsus Pharmaceuticals | Xdemvy | $13 | 1 payment
|
2023: $420
| Bausch & Lomb Americas | Miebo | $165 | 4 payments
|
| Oyster Point Pharma | Tyrvaya | $136 | 6 payments
|
| Novartis Pharmaceuticals | Xiidra | $56 | 3 payments
|
| Sun Pharmaceutical Industries | Cequa | $39 | 1 payment
|
| Horizon Therapeutics plc | Tepezza | $24 | 1 payment
|
2022: $204
| Novartis Pharmaceuticals | Xiidra | $123 | 7 payments
|
| Sun Pharmaceutical Industries | Cequa | $34 | 1 payment
|
| Oyster Point Pharma | Tyrvaya | $26 | 1 payment
|
| Thea Pharma | None | $20 | 1 payment
|
2021: $167
| Bausch & Lomb a division of Bausch Health US | Vyzulta | $93 | 4 payments
|
| Novartis Pharmaceuticals | Xiidra | $31 | 2 payments
|
| Sun Pharmaceutical Industries | Cequa | $24 | 1 payment
|
| Allergan | Durysta | $19 | 1 payment
|
2020: $24
| Bausch & Lomb a division of Bausch Health US | Lotemax Sm | $24 | 1 payment
|
2019: $536
| Novartis Pharmaceuticals | Xiidra | $227 | 2 payments
|
| Sun Pharmaceutical Industries | Cequa | $145 | 5 payments
|
| Aerie Pharmaceuticals | Rhopressa | $129 | 2 payments
|
| Akorn | Azasite | $22 | 1 payment
|
| Bausch & Lomb a division of Bausch Health US | Lotemax Sm | $14 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 89.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1871546010
- Licence
- CA G11266California G11266: Current · expires 2028-02-29
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 123 Di Salvo Ave, Suite 20, San Jose, CA, 95128
- NPI first listed
- 2006-05-18
- NPI last updated
- 2016-01-06
This is when the NPI record was last certified, not a medical board exam.